Showing posts with label CEP-1347. Show all posts
Showing posts with label CEP-1347. Show all posts

Thursday, August 28, 2008

Clinical Trial Results of CEP-1347

Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease.
Parkinson Study Group PRECEPT Investigators.